1. Home
  2. STAA vs ABCL Comparison

STAA vs ABCL Comparison

Compare STAA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$24.82

Market Cap

867.9M

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.76

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STAA
ABCL
Founded
1982
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
867.9M
1.1B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
STAA
ABCL
Price
$24.82
$3.76
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$22.81
$8.40
AVG Volume (30 Days)
1.3M
2.3M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$239,442,000.00
$75,128,000.00
Revenue This Year
$28.87
N/A
Revenue Next Year
$7.49
$23.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$15.59
$1.94
52 Week High
$30.81
$6.52

Technical Indicators

Market Signals
Indicator
STAA
ABCL
Relative Strength Index (RSI) 67.51 62.45
Support Level $23.79 $3.35
Resistance Level $27.59 $3.80
Average True Range (ATR) 1.15 0.17
MACD 0.79 0.04
Stochastic Oscillator 77.83 87.70

Price Performance

Historical Comparison
STAA
ABCL

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: